An investigational COVID-19 vaccine developed by Janssen Pharmaceuticals appears to be safe and effective at preventing moderate and severe COVID-19 in adults, according to an interim analysis of Phase 3 clinical data conducted Jan. 21. The vaccine, called Ad.26.COV2.S or JNJ-78436725, requires only a single injection and can be stored in a refrigerator for months.Continue reading
Category Archives: AZBio News
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
- Vaccine Candidate 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19, 28 Days after Vaccination
- 85% Effective Overall in Preventing Severe Disease and Demonstrated Complete Protection Against COVID-19 related Hospitalization and Death as of Day 28
- Protection Against Severe Disease Across Geographies, Ages, and Multiple Virus Variants, including the SARS-CoV-2 Variant from the B.1.351 Lineage [1] Observed in South Africa
- Single-shot compatible with standard vaccine distribution channels provides important tool in pandemic setting
[1] The B.1.351 lineage also known as 501Y.V2 variant and 20H/501Y.V2 (formerly 20C/501Y.V2) is a variant of SARS-CoV-2, the virus that causes COVID-19Continue reading
A Better Way to Diagnose Breast Cancer?
TGEN-LED STUDY RESULTS SUGGEST A MORE ACCURATE DIAGNOSTIC FOR BREAST CANCER
Proteomics-based technology could help verify mammography screening
PHOENIX, Ariz. — Jan. 26, 2021 — Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Written by
Equality Health and General Atlantic Announce Strategic Partnership to Help Drive Continued Expansion of Equality’s Value-Based Primary Care Network and Technology Solutions
Strategic investment from General Atlantic to help enable Equality Health in furthering its mission of increasing access to care, lowering costs and improving outcomes for underserved individuals, families and communities
Equality Health to acquire actuarial firm, Daraja Services, to deepen healthcare economics capabilitiesContinue reading
Arizona executives named to lead Statewide bioscience committee
PHOENIX—A medical-technology executive and a former state legislator have been named the new leaders of Arizona’s statewide committee overseeing the advancement of the state’s bioscience ecosystem.Continue reading
Humabiologics, Inc. Launches 2021 HumaScholar Grant Program
Humabiologics, Inc. is announcing its first HumaScholar Grant. Each HumaScholar will receive a $3,000 research grant in the form of credit to utilize human-derived biomaterials from Humabiologics.Continue reading
TGen-NAU study: COVID-19 virus triggers antibodies from previous coronavirus infections
Findings suggest that prior immune experience could affect the course of patient’s diseaseContinue reading
Align Technology Establishes New Global Corporate Headquarters In Tempe, Arizona
San Jose, California Campus Becomes West Coast Regional Headquarters and New Digital Innovation CenterContinue reading
Opportunty Alert: EMERGEAZ Fast Grants
In partnership with the Arizona Governor’s Office, invisionAZ and StartupAZ are offering financial support to the state’s startups through the EMERGEAZ Fast Grant. Local entrepreneurs and startups with emerging technologies designed to address the impacts of the pandemic are encouraged to apply. There is a total of $1 million in the fund and grants will be awarded in amounts ranging from $25,000 to $50,000.Continue reading
Governor Ducey’s Budget Focuses On Education, Tax Relief
News Release: January 15, 2021
Budget Also Invests In Public Health, Public Safety, Infrastructure And Wildfire PreventionContinue reading